Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Govt. of India
logo
logo
logo
logo
Menu

logo

HOME/ PUBLICATIONS/PATENTS

Publications / Patents >
2026 >
2025 >
2024 >
2023 >
2022 >
2021 >
2020 >
2019 >
2018 >
2017 >
2016 >
2015 >
2014 >
2013 >
2012 >
2011 >
2010/2009 >
Patents >
Book Chapters >

Publications in 2025

Publications are the primary method for reporting and long-term documentation of the research conducted at the NIPER-Hyderabad. Here the list of publications published in year wise...


  1. Kumawat, A.; Ambati, H.; Galla, M. S.; Kuralkar, K.; M. Venkatesh; Ghosh, B.; Shankaraiah, N. β-Carbolines Linked γ-Amino Butyric Acid/p-Amino Benzoic Acid Based Carboxamides as Histone Deacetylase Inhibitors: Design, Synthesis, Cytotoxicity and In Silico Studies. International Journal of Biological Macromolecules 2025, 334, 149131. https://doi.org/10.1016/j.ijbiomac.2025.149131
  2. Dastari, S.; Pasupuleti, V.; Madhurya, M. S.; Sharma, A.; Godugu, C.; Shankaraiah, N. Design, Synthesis, and Cytotoxicity Evaluation of Styrylspirooxindole Carboxamides as Potential Tubulin and VEGFR-2 Dual Inhibitors. ChemMedChem 2025, 20, e202500634. https://doi.org/10.1002/cmdc.202500634
  3. Khan, M. A.; Saha, S.; Sakla, A. P.; Sathish, M.; Shankaraiah, N. Metal-Free Amination of Imidazoheteroarenes Employing p-Quinone Diimides (p-QDIs). ChemistrySelect 2025, 10, e04429. https://doi.org/10.1002/slct.202504429
  4. Khan, M. A.; Rallabandi, N. C.; Raman, P. K.; Sharma, A.; Godugu, C.; Shankaraiah, N. Design, Synthesis, and Cytotoxicity Evaluation of 1,2,3-Triazole-Linked β-Carboline–Benzimidazole Hybrids as Tubulin Polymerization Inhibitors. New Journal of Chemistry 2025, 49, 17716–17729. https://doi.org/10.1039/d5nj03098f
  5. Chauhan, Y.; Kumawat, A.; Singh, A.; Shankaraiah, N.; Kaki, V. R. Unravelling the Potential of Small Molecule Tumor Necrosis Factor-α (TNF) Inhibitors: A Comprehensive Review. Bioorganic & Medicinal Chemistry 2025, 130, 118344. https://doi.org/10.1016/j.bmc.2025.118344
  6. Dastari, S.; Pradhan, S.; Thakur, V.; Reddyrajula, R.; Chilvery, S.; Godugu, C.; Shankaraiah, N. Design, Synthesis and Biological Evaluation of Spirocyclopropyl Oxindole-Piperazine/Morpholine-Based Carboxamides as Potential Anticancer Agents. Bioorganic Chemistry 2025, 163, 108784. https://doi.org/10.1016/j.bioorg.2025.108784
  7. Kumari, P.; Dastari, S.; Singitham, S.; Avvaru, S. J.; Shankaraiah, N. Regioselective Multi-Component Approach Promoted by p-TSA: A Facile Synthetic Access to 3,5-Disubstituted 4-Pyridinone Frameworks. Asian Journal of Organic Chemistry 2025, 14, e00445. https://doi.org/10.1002/ajoc.202500445
  8. Kanp, T.; Dhuri, A.; Aalhate, M.; Manoharan, B.; Rode, K.; Munagalasetty, S.; Sarma, A. V. S.; Kshirsagar, P.; Shankaraiah, N.; Bhandari, V.; Sharma, B.; Singh, P. K. Investigation of a Palbociclib and Naringin Co-Amorphous System to Ameliorate Anticancer Potential: Insights on In Silico Modeling, Physicochemical Characterization, Ex Vivo Permeation, and In Vitro Efficacy. Molecular Pharmaceutics 2025, 22, 2446–2465. https://doi.org/10.1021/acs.molpharmaceut.4c01224
  9. Dastari, S.; Panda, B.; Rasane, S.; Reddyrajula, R.; Godugu, C.; Shankaraiah, N. Design, Synthesis of 1H-Benzimidazol-2-yl-Enaminone Hybrids as Tubulin Polymerization Inhibitors and In Vitro Cytotoxicity Studies. SYNLETT 2025, 36, 2855–2863. https://doi.org/10.1055/s-0043-1775494
  10. Gupta, S.; Galla, M. S.; Suhas, K. P.; Shankaraiah, N. Carboxylic Acids as Enabling Directing Groups in C-H Activation and Functionalization: A Decade Review. Advanced Synthesis & Catalysis 2025, 367, e202500093. https://doi.org/10.1002/adsc.202500093
  11. Jha, A.; Dastari, S.; Barve, N. M.; Shankaraiah, N. Oximes and Hydrazones as Versatile Directing Groups: A Critical Review on Recent Advances of C-H Activation and Functionalization. Tetrahedron 2025, 179, 134634. https://doi.org/10.1016/j.tet.2025.134634
  12. Khan, M. A.; Parida, K. K.; Sowmya, D.; Rallabandi, N. C.; Kalia, N. P.; Shankaraiah, N. Design and Synthesis of β-Carboline-Benzofuran Based Hybrids as Antibacterial Agents Against Staphylococcus aureus. Bioorganic & Medicinal Chemistry Letters 2025, 123, 130220. https://doi.org/10.1016/j.bmcl.2025.130220
  13. Reddyrajula, R.; Varshini, K. P.; Shankaraiah, N. Recent Developments of Benzimidazole Based Analogs as Potential Tubulin Polymerization Inhibitors: A Critical Review. Bioorganic & Medicinal Chemistry Letters 2025, 122, 130167. https://doi.org/10.1016/j.bmcl.2025.130167
  14. Valapil, D. G.; Devabattula, G.; Barahdia, A. S.; Godugu, C.; Shankaraiah, N. Development of 3-Indolyl Substituted Phenyl Pyrazolo-Carboxamide Hybrids as Potential Type II VEGFR-2 Inhibitors and In Vitro Cytotoxicity Studies. Bioorganic & Medicinal Chemistry Letters 2025, 117, 130070. https://doi.org/10.1016/j.bmcl.2024.130070
  15. Golla, V. M.; Chary, P. S.; Naik, D. D.; Pilli, P.; Kommalapati, H. S.; Ramteke, A.; Mehra, N. K.; Samanthula, G. Separation, identification, and characterization of transformation products related to relugolix upon subjecting to in vitro gastrointestinal fluids utilizing liquid chromatography, mass spectrometry, and nuclear magnetic resonance spectroscopy. Separation Science Plus 2025, 8 (1), e202400195. https://doi.org/10.1002/sscp.202400195
  16. Khemchandani, R.; Pardhi, E.; Goud, S.; Tomar, D. S.; Medtiya, P.; Khushwaha, B. S.; Dhiman, V.; Golla, V. M.; Shaikh, N.; Godugu, C. Multi-method coamorphous systems of lumefantrine with alpha ketoglutaric acid: Comprehensive characterization, biological evaluation and stability analysis. International Journal of Pharmaceutics 2025, 669, 125056. https://doi.org/10.1016/j.ijpharm.2024.125056
  17. Pilli, P.; Chaganti, S.; Golla, V. M.; Kommalapati, H. S.; Nayak, B. V.; Samanthula, G. Separation of Oxidative Degradation Products of the Anti-Cancer Drug Gilteritinib Fumarate by Liquid Chromatography with Photodiode Array and Mass Spectrometric Detection. Journal of Analytical Chemistry 2025, 80 (4), 684–692. https://doi.org/10.1134/S106193482570011X
  18. Mouli, H. C.; Harini, D.; Shaikh, N.; Khemchandani, R.; Shreya, S.; Jana, A.; Samanthula, G. In silico characterization of indole-substituted densely functionalized pyrrole against breast cancer: Integrating DFT, molecular docking, MD simulations, and ADME analysis. Journal of Molecular Structure 2025, 1328, 141375. https://doi.org/10.1016/j.molstruc.2025.141375
  19. Dande, A.; Chandra Mouli, H.; Nandy, J.; Shreya, S.; Pallaprolu, N.; Samanthula, G.; P, R. Risk assessment, detection and control of mutagenic impurities in pharmaceuticals: Emphasis on nitrosamines. Critical Reviews in Analytical Chemistry 2025, 1–42. https://doi.org/10.1080/10408347.2025.2517357
  20. Dhiman, V.; Khemchandani, R.; Velip, L.; Mishra, D.; Samanthula, G. Understanding the degradation behavior of masitinib by Stress testing, UHPLC, HRMS, NMR, APCI-MS, DFT and prediction of toxicity using in silico tools. Journal of Pharmaceutical Sciences 2025, 103958. https://doi.org/10.1016/j.xphs.2025.103958
  21. Jain, J. K.; Sujatha, K.; Sheelarani, T.; Trivedi, H.; Khemchandani, R.; Gananadhamu, S. Analytical Quality by Design Enabled Green RP-HPLC Method Development and Validation for the Simultaneous Quantitation of the Cleaning Residues of Osimertinib, Binimetinib, and Erdafitinib: An Approach to Prevent the Cross-Contamination in Shared Facilities of Pharmaceutical Manufacturing. Separation Science Plus 2025, 8 (9), e70102. https://doi.org/10.1002/sscp.70102
  22. Golla, V. M.; Pilli, P.; Padhy, H. P.; Samanthula, G.; Gupta, A. K. Analytical challenges in the mavacamten impurity analysis: Exploring various cutting edge analytical methods to achieve mass balance for the accurate quantification of analytes. Journal of the Indian Chemical Society 2025, 102082. https://doi.org/10.1016/j.jics.2025.102082
  23. Chaganti, S.; Shaikh, N.; Pimpre, K.; Barik, P.; Jadhav, A.; Chilvery, S.; Talari, K.; Godugu, C.; Samanthula, G. Structural characterization of in vivo and in vitro metabolites of bosutinib by LC-MS/MS, in combination with the in silico methodologies for toxicity and metabolism prediction. Drug Metabolism and Disposition 2025, 100161. https://doi.org/10.1016/j.dmd.2025.100161
  24. Chaganti, S.; Chauhan, U.; Harini, D.; Mouli, H. M. C.; Nayak, B. V.; Samanthula, G. Stress Degradation Study of Bosutinib and Structural Elucidation of Its Degradation Impurities by Using LC-Q-TOF-MS/MS and NMR. Journal of Mass Spectrometry 2025, 60 (10), e5180. https://doi.org/10.1002/jms.5180
  25. Khemchandani, R.; Pardhi, E.; Jadhav, A.; Devi, P.; Roshitha, K.; Bhatt, N.; Godugu, C.; Mehra, N. K.; Samanthula, G. Integrated experimental, computational and machine learning approaches for the development of Apremilast-Aceclofenac coamorphous systems. International Journal of Pharmaceutics 2025, 126283. https://doi.org/10.1016/j.ijpharm.2025.126283
  26. Bhatt, N.; Sonaje, D.; Golla, V. M.; Khemchandani, R.; Gupta, A. K.; Samanthula, G. Identification and characterization of forced degradation products of lumateperone tosylate by LC-HRMS, GC-MS, NMR, and in silico toxicity prediction. Journal of Pharmaceutical and Biomedical Analysis Open 2025, 6, 100085. https://doi.org/10.1016/j.jpbao.2025.100085
  27. Singh, P.; Samanthula, G.; Jasti, M. C.; Ramchandran, R. K.; Kodam, C.; Suraj; Singh, N.; Bhadoriya, K. Targeted Ultra-High Performance Liquid Chromatography–Electrospray Ionization Triple Quadrupole Mass Spectrometry-Based Quantification of Diosgenin in Hellenia speciosa for Its Wild Populations Screening: A Quality Control Assessment. Separation Science Plus 2025, 8 (12), e70167. https://doi.org/10.1002/sscp.70167
  28. Jain, J. K.; Sujatha, K.; Sheelarani, T.; Trivedi, H.; Khemchandani, R.; Gananadhamu, S. An Eco-Friendly and Quality-by-Design Optimized Synchronous Spectrofluorescence Method for the Simultaneous Determination of Cleaning Residues of Anticancer Drugs Darolutamide and Enzalutamide From Manufacturing Surfaces. Luminescence 2025, 40 (12), e70376. https://doi.org/10.1002/bio.70376
  29. Kumar, M.; Arya, D. K.; Almujri, S. S.; Chidambaram, K.; Pandey, P.; Kumar, A.; Pandey, G.; Sharma, A.; Chaurasiya, M.; Babu, M. A.; Kumar, R. V.; Gupta, R. K.; Srivastava, S.; Rajinikanth, P. S. Mulberry Silk Worm Pupae Oil and Prussian Blue Nanoparticle Enriched Multi-Faceted Polyvinyl Alcohol Nanofiber for Infectious Full Thickness Skin Wound Healing. Tissue Engineering and Regenerative Medicine 2025, 22, 1119–1140. https://doi.org/10.1007/s13770-025-00751-8
  30. Pandey, G.; Famta, P.; Shah, S.; Kumar, R.; Wagh, S.; Vambhurkar, G.; Sharma, A.; Sharma, A.; Shinde, S.; Singh, G.; Chandankar, S.; Dalal, A.; Kalia, N. P.; Asthana, A.; Srivastava, S. Disulfiram-Encapsulated Poly(caprolactone) Nanofiber Scaffolds for Oral Squamous Cell Carcinoma Management. Bionanoscience 2025, 15. https://doi.org/10.1007/s12668-025-02153-5
  31. Joga, R.; Vambhurkar, G.; Srivastava, S. Regulatory Science-Aligned Development and Pre-Clinical Evaluation of Novel Lidocaine-Loaded Nanoemulgel for Psoriasis Management. Journal of Investigative Dermatology 2025, 145, e64. https://doi.org/10.1016/j.jid.2025.09.218
  32. Gandhi, K.; Joga, R.; Sowndharya, M.; Vijay, G. K.; Waiker, S.; Yerram, S.; Raghuvanshi, R. S.; Srivastava, S. Unlocking Generic Market Access: A Retrospective Analysis of USFDA Paragraph IV Filings (2020–2024). Therapeutic Innovation & Regulatory Science 2025, 59, 1380–1393. https://doi.org/10.1007/s43441-025-00831-w
  33. Joga, R.; Yerram, S.; Patnam, J. D.; Choudhary, K. K.; Varpe, P.; Raghuvanshi, R. S.; Srivastava, S. Unraveling the Policies, Legislations, and Regulations of Psychedelics in Australia, Canada, Netherlands, New Zealand, and India. Health Policy 2025, 161, 105392. https://doi.org/10.1016/j.healthpol.2025.105392
  34. Ahmad, A.; Simran, S.; Kalokhe, V. M.; Musthafa, F.; Gangawane, V. S.; Choudhary, K. K.; Raghuvanshi, R. S.; Srivastava, S. Genetic Renaissance: A Cross-Regional Analysis of the Approval Landscape of Authorised Gene Therapeutics in Paediatrics, Challenges and Future Prospects. Journal of Community Genetics 2025, 16, 513–528. https://doi.org/10.1007/s12687-025-00799-y
  35. Prasad, S. B.; Shinde, A.; Srinivasarao, D. A.; Famta, P.; Shah, S.; Kolipaka, T.; Pandey, G.; Gaonker, D.; Vambhurkar, G.; Khairnar, P.; Kumar, R.; Dikundwar, A. G.; Kanchupalli, V.; Srivastava, S. Metal-Organic Frameworks as Therapeutic Chameleons: Revolutionizing the Cancer Therapy Employing Novel Nanoarchitectonics. Asian Journal of Pharmaceutical Sciences 2025, 20, 101054. https://doi.org/10.1016/j.ajps.2025.101054
  36. Prasannanjaneyulu, V.; Nene, S.; Vambhurkar, G.; Tryphena, K. P.; Khatri, D. K.; Srivastava, S. Amelioration of Imiquimod-Induced Psoriasis in the Mice Model by Topical Delivery of Phosphodiesterase 4 Inhibitor Roflumilast Incorporated Nanoemulgel. Pharmaceutical Development and Technology 2025, 30, 1083–1093. https://doi.org/10.1080/10837450.2025.2505004
  37. Jain, A.; Kolipaka, T.; Pandey, G.; Priyadarshinee, A.; Puri, N.; Shinde, S.; Srivastava, S. Innovative Approaches to Diabetic Wound Healing: Focusing on ROS and Redox Signals. Molecular Pharmaceutics 2025, 22, 5738–5766. https://doi.org/10.1021/acs.molpharmaceut.5c00491
  38. Bahuguna, D.; Amulya, E.; Arya, S.; Loharkar, S.; Vambhurkar, G.; Bhattacharjee, S.; Chandanapalli, D. K.; Madan, J.; Srivastava, S. Unlocking Therapeutic Potential in Traumatic Brain Injury: Exploring Microenvironmental Targets, Signaling Pathways and Translational Hurdles. Inflammopharmacology 2025, 33, 5113–5144. https://doi.org/10.1007/s10787-025-01923-7
  39. Sowndharya, M.; Joga, R.; Gandhi, K.; Vijay, G. K.; Waikar, S.; Yerram, S.; Raghuvanshi, R. S.; Srivastava, S. Navigating the Trends in USFDA Authorized Generic Approvals (2019–2024): Enhancing Healthcare Accessibility and Affordability. Therapeutic Innovation & Regulatory Science 2025, 59, 1053–1063. https://doi.org/10.1007/s43441-025-00806-x
  40. Famta, P.; Shah, S.; Vambhurkar, G.; Kumar, R.; Pandey, G.; Singh, G.; Wagh, S.; Arya, D. K.; Kanaujiya, S.; Sharma, A.; Prasad, S. B.; Shinde, A.; Chandankar, S.; Shinde, S.; Sharma, A.; Rajinikanth, P. S.; Kalia, N. P.; Asthana, A.; Srivastava, S. Establishment and Evaluation of Paclitaxel and Simvastatin-Laden Nanofibers for Post-Surgical Tumor Recurrence in Breast Cancer. Bionanoscience 2025, 15. https://doi.org/10.1007/s12668-025-01935-1
  41. Khairnar, P.; Kolipaka, T.; Pandey, G.; Phatale, V.; Hedaoo, A.; Srivastava, S. Formulating Pharma-, Nutra-, and Cosmeceutical Products from Herbal Substances. Formulating Pharma-, Nutra-, and Cosmeceutical Products from Herbal Substances: Dosage Forms and Delivery Systems 2025, 299–321. https://doi.org/10.1002/9781119769484.ch11
  42. Abraham, N.; Kolipaka, T.; Pandey, G.; Arya, D. K.; Sharma, A.; Vambhurkar, G.; Kumar, R.; Rajinikanth, P. S.; Srivastava, S. Quality by Design (QbD) Accredited Naringenin-Loaded Chitosan Nanoparticles Impregnated Gel for Diabetic Wound Healing: Formulation, Optimization, In Silico and In Vitro Characterization. Journal of Drug Delivery Science and Technology 2025, 114, 107418. https://doi.org/10.1016/j.jddst.2025.107418
  43. Sharma, A.; Shah, S.; Wagh, S.; Pandey, G.; Pradhan, A. K.; Shukla, S.; Thomas, S. P.; Dikundwar, A. G.; Srivastava, S. Ever-Increasing Role of Computational Tools in Solid-State Pharmaceutics: Advancing Drug Development with Enhanced Molecular Understanding and Risk Assessment. Molecular Pharmaceutics 2025, 22, 5165–5192. https://doi.org/10.1021/acs.molpharmaceut.5c00296
  44. Phatale, V.; Khairnar, P.; Shukla, S.; Puri, N.; Sahane, P.; Srivastava, S. Nano-Biohybrids with Cell-Penetrating Peptides: A Molecular Trojans for Glioblastoma Precision Medicine. International Journal of Pharmaceutics 2025, 683, 126077. https://doi.org/10.1016/j.ijpharm.2025.126077
  45. Sahane, P.; Khairnar, P.; Hedaoo, A.; Shukla, S.; Puri, N.; Phatale, V.; Prasad, S. B.; Shinde, A.; Vambhurkar, G.; Srivastava, S. Hyaluronic Acid-Infused Microneedles: Unlocking the Revolutionary Era of Targeted Melanoma Treatment. European Polymer Journal 2025, 238, 114205. https://doi.org/10.1016/j.eurpolymj.2025.114205
  46. Famta, P.; Shah, S.; Sharma, A.; Vambhurkar, G.; Singh, Y.; Mourya, A.; Srinivasarao, D. A.; Prasad, S. B.; Shinde, A.; Pandey, G.; Thareja, S.; Madan, J.; Srivastava, S. Hydroxy Propyl β-Cyclodextrin Complexes of Olaparib: Amalgamation of In Silico, In Vitro and In Vivo Approaches for Bioavailability Enhancement. Journal of Molecular Structure 2025, 1336, 142077. https://doi.org/10.1016/j.molstruc.2025.142077
  47. Konda, P.; Yerram, S.; Khader, M. N.; Joga, R.; Nizam, M. V. P.; Girhe, M.; A. C. S.; Srivastava, S. USFDA Warning Letters: An Analysis of Compliance in Over-the-Counter Drug Products (2020–2024). Journal of Pharmaceutical Innovation 2025, 20. https://doi.org/10.1007/s12247-025-10061-0
  48. Musthafa, F.; Simran, S.; Gangawane, V. S.; Kalokhe, V. M.; Ahmad, A.; Srivastava, S. The Evolution of Turbocharged Cancer Therapeutics: How Regulatory Flexibility Has Driven Accelerated Cancer Biologics Approvals in the United States (1993–2023). Journal of Pharmaceutical Innovation 2025, 20. https://doi.org/10.1007/s12247-025-10059-8
  49. Jain, N.; Shahrukh, S.; Famta, P.; Shah, S.; Vambhurkar, G.; Srinivasarao, D. A.; Sharma, A.; Pandey, G.; Wagh, S.; Shinde, S.; Khan, A.; Kumar, P.; Srivastava, S. Combating Breast Cancer-Associated Metastasis Using Paclitaxel and Tranilast-Loaded Human Serum Albumin Nanoparticles. Drug Development and Industrial Pharmacy 2025, 51, 786–798. https://doi.org/10.1080/03639045.2025.2509861
  50. Mourya, A.; Kumar, S.; Shah, S.; Famta, P.; Kanchupalli, V.; Srivastava, S.; Madan, J. Quality-by-Design-Assisted Laboratory Scale-Up of Lipid Nanoparticles of Stearic Acid-Raloxifene Hydrochloride Conjugate: A Pathway for Enhanced Oral Bioavailability via Lymphatic Uptake. Molecular Pharmaceutics 2025, 22, 3868–3884. https://doi.org/10.1021/acs.molpharmaceut.5c00139
  51. Wagh, S.; Khairnar, P.; Pandey, G.; Phatale, V.; Srivastava, S. Minimally Invasive Injectable Hydrogels. Transdermal Applications of Minimally Invasive Drug Delivery Systems: Current Trends and Future Perspectives 2025, 23–51. https://doi.org/10.1007/978-981-96-6275-3_2
  52. Kolipaka, T.; Amulya, E.; Vambhurkar, G.; Shukla, S.; Srivastava, S. Introduction to Minimally Invasive Drug Delivery System (MIDDS). Transdermal Applications of Minimally Invasive Drug Delivery Systems: Current Trends and Future Perspectives 2025, 1–21. https://doi.org/10.1007/978-981-96-6275-3_1
  53. Nizam, V. P. M.; Yerram, S.; Ajmal, C. S.; Raghuvanshi, R. S.; Srivastava, S. Unraveling Trends in USFDA’s CDER-Regulated Drug Shortages (2019–2024): Causes, Patterns, and Strategic Insights for the Future. Journal of Pharmaceutical Innovation 2025, 20. https://doi.org/10.1007/s12247-025-10009-4
  54. Shah, S.; Famta, P.; Kumar, R.; Vambhurkar, G.; Pandey, G.; Shinde, A.; Prasad, S. B.; Sharma, A.; Sharma, A.; Kanaujiya, S.; Arya, D. K.; Kolipaka, T.; Wagh, S.; Rajinikanth, P. S.; Srivastava, S. QbD Manoeuvred Niclosamide Laden Polylactic-co-Glycolic Acid Nanoparticles-Impregnated Gelatin Nanofibers for the Management of Oral Carcinoma. Bionanoscience 2025, 15. https://doi.org/10.1007/s12668-025-01833-6
  55. Nene, S.; Devabattula, G.; Vambhurkar, G.; Tryphena, K. P.; Khatri, D. K.; Godugu, C.; Singh, P. K.; Srivastava, S. Topical Delivery of Baricitinib-Impregnated Nanoemulgel: A Promising Platform for Inhibition of JAK-STAT Pathway for the Effective Management of Atopic Dermatitis. Drug Delivery and Translational Research 2025, 15, 2200–2219. https://doi.org/10.1007/s13346-024-01732-5
  56. Shinde, S.; Shah, S.; Famta, P.; Wagh, S.; Pandey, G.; Sharma, A.; Vambhurkar, G.; Jain, A.; Srivastava, S. Next-Generation Transformable Nanomedicines: Revolutionizing Cancer Drug Delivery and Theranostics. Molecular Pharmaceutics 2025, 22, 2783–2806. https://doi.org/10.1021/acs.molpharmaceut.4c01495
  57. Wangmo, T.; Garg, K.; Ibrahim, A. A.; Srivastava, S.; Famta, P.; Singh, S. K.; Gulati, M.; Dua, K.; Kaur, J. Oral Insulin Delivery by Spatiotemporal Polymeric Micelles: Existing Barriers, Status Quo and Opportunities. European Polymer Journal 2025, 233, 113981. https://doi.org/10.1016/j.eurpolymj.2025.113981
  58. Sahane, P.; Puri, N.; Khairnar, P.; Phatale, V.; Shukla, S.; Priyadarshinee, A.; Srivastava, S. Harnessing Folate Receptors: A Comprehensive Review on the Applications of Folate-Adorned Nanocarriers for the Management of Melanoma. ACS Applied Bio Materials 2025, 8, 3623–3656. https://doi.org/10.1021/acsabm.5c00077
  59. Puri, N.; Sahane, P.; Phatale, V.; Khairnar, P.; Shukla, S.; Priyadarshinee, A.; Jain, A.; Srivastava, S. Nano-Chameleons: A Review on Cluster of Differentiation-Driven Immune Cell-Engineered Nanoarchitectonics for Non-Small Cell Lung Cancer. International Journal of Biological Macromolecules 2025, 310, 143440. https://doi.org/10.1016/j.ijbiomac.2025.143440
  60. Priyadarshinee, A.; Amulya, E.; Vambhurkar, G.; Jain, A.; Puri, N.; Sahane, P.; Srivastava, S. Unveiling the Revolutionary Approach for Psoriasis Management: Leveraging the Breakthrough Capabilities of Hyaluronic Acid. International Journal of Biological Macromolecules 2025, 310, 143089. https://doi.org/10.1016/j.ijbiomac.2025.143089
  61. Jaiswal, P.; Pandey, G.; Kumar, S.; Kolipaka, T.; Misra, S. K.; Kanaujiya, S.; Rajinikanth, P. S.; Srivastava, S.; Yadav, A. K. Advancements in Skin Tissue Regeneration: Unveiling Emerging Treatment Strategies, Regulatory Perspectives, and Future Directions for Enhanced Healing. Journal of Drug Delivery Science and Technology 2025, 108, 106872. https://doi.org/10.1016/j.jddst.2025.106872
  62. Arya, D. K.; Pandey, P.; Kumar, A.; Chidambaram, K.; Al Fatease, A.; Pandey, G.; Srivastava, S.; Rajinikanth, P. S. Dual-Ligand Functionalized Liposomes with iRGD/Trastuzumab Co-Loaded with Gefitinib and Lycorine for Enhanced Metastatic Breast Cancer Therapy. Journal of Liposome Research 2025, 35, 173–187. https://doi.org/10.1080/08982104.2025.2457453
  63. M, S.; Joga, R.; Gandhi, K.; Yerram, S.; Raghuvanshi, R. S.; Srivastava, S. Exploring the Clinical Trials, Regulatory Insights, and Challenges of PROTACs in Oncology. Seminars in Oncology 2025, 52, 152339. https://doi.org/10.1016/j.seminoncol.2025.152339
  64. Tandulje, A. A.; Varpe, P. C.; Chaugule, P. D.; Saji, S.; Nizar, F.; Raghuvanshi, R. S.; Srivastava, S. Cell and Gene Therapy Products: Navigating the Regulatory Landscape of Paradigm Approvals in the US (2020 to 2024). Journal of Pharmaceutical Innovation 2025, 20. https://doi.org/10.1007/s12247-025-09973-8
  65. Girhe, M. K.; Yerram, S.; Ajmal, S. C.; Muhammed Nizam, V. P.; Joga, R.; Khader, N.; Konda, P.; Raghuvanshi, R. S.; Srivastava, S. Enhancing Pharmaceutical Accessibility: Evaluating the Impact of Competitive Generic Therapy Exclusivity on Rapid Access of Generics into the U.S. Market (2019–2024). Journal of Pharmaceutical Innovation 2025, 20. https://doi.org/10.1007/s12247-025-09969-4
  66. Kalokhe, V. M.; Simran, S.; Ahmad, A.; Musthafa, F.; Gangawane, V. S.; Raghuvanshi, R. S.; Srivastava, S. Unveiling Gaps and Demographic Influences in Alzheimer’s Therapy: A Data-Centric Study of FDA-Approved Late-Phase Clinical Trials. Neurological Sciences 2025, 46, 3085–3095. https://doi.org/10.1007/s10072-025-08135-5
  67. Pandey, G.; Kolipaka, T.; Srinivasarao, D. A.; Abraham, N.; Jain, A.; Srivastava, S. Navigating the Complexities of Diabetic Foot Ulcers: From Pathophysiology to Advanced Treatment Strategies. Journal of Drug Delivery Science and Technology 2025, 107, 106852. https://doi.org/10.1016/j.jddst.2025.106852
  68. Kanaujia, K. A.; Wagh, S.; Pandey, G.; Phatale, V.; Khairnar, P.; Kolipaka, T.; Rajinikanth, P. S.; Saraf, S. A.; Srivastava, S.; Kumar, S. Harnessing Marine Antimicrobial Peptides for Novel Therapeutics: A Deep Dive into Ocean-Derived Bioactives. International Journal of Biological Macromolecules 2025, 307, 142158. https://doi.org/10.1016/j.ijbiomac.2025.142158
  69. Shukla, S.; Khairnar, P.; Hedaoo, A.; Phatale, V.; Vambhurkar, G.; Wagh, S.; Sharma, A.; Srivastava, S. Harnessing Peptide-Based Nanotherapeutics: Pioneering Melanoma Management from Diagnosis to Theranostics. Journal of Drug Delivery Science and Technology 2025, 107, 106811. https://doi.org/10.1016/j.jddst.2025.106811
  70. Shah, S.; Famta, P.; Vambhurkar, G.; Sharma, A.; Mourya, A.; Srinivasarao, D. A.; Shinde, A.; Prasad, S. B.; Pandey, G.; Madan, J.; Srivastava, S. Exploration of Abiraterone Acetate Loaded Nanostructured Lipid Carriers for Bioavailability Improvement and Circumvention of Fast-Fed Variability. Drug Delivery and Translational Research 2025, 15, 1074–1091. https://doi.org/10.1007/s13346-024-01657-z
  71. Bellapu, K. K.; Mergu, T.; Shirsath, N. V.; Shende, P. A.; Vasu, P. Y.; Jindal, D.; Grover, P.; Srivastava, S.; Sindhu, R. K.; Kumar, S. Regulatory Aspects of Antioxidants. Antioxidants: Nature’s Defense against Diseases 2025, 613–628. https://doi.org/10.1002/9781394270576.ch19
  72. Wagh, S. S.; Famta, P.; Shah, S.; Vambhurkar, G.; Pandey, G.; Sikder, A.; Singh, G.; Shukla, S.; Sharma, A.; Prasad, S. B.; Shinde, A.; Kumar, R.; Kalia, N. P.; Raghuvanshi, R. S.; Srivastava, S. Navigating the Brain: Harnessing Endogenous Cellular Hitchhiking for Targeting Neoplastic and Neuroinflammatory Diseases. Asian Journal of Pharmaceutical Sciences 2025, 20, 101040. https://doi.org/10.1016/j.ajps.2025.101040
  73. Abraham, N.; Pandey, G.; Kolipaka, T.; Negi, M.; Srinivasarao, D. A.; Srivastava, S. Exploring Advancements in Polysaccharide-Based Approaches: The Cornerstone of Next-Generation Cartilage Regeneration Therapeutics. International Journal of Biological Macromolecules 2025, 306, 141352. https://doi.org/10.1016/j.ijbiomac.2025.141352
  74. Gupta, R.; Pandey, G.; Kumar, A.; Kapoor, A.; Wagh, S.; Kolipaka, T.; Famta, P.; Mishra, A.; Srivastava, S.; Misra, S. K. Harnessing Electrospun Nanofibers for Comprehensive Oral Disease Management: Current Trends and Future Perspectives. Journal of Drug Delivery Science and Technology 2025, 106, 106681. https://doi.org/10.1016/j.jddst.2025.106681
  75. Shah, S.; Famta, P.; Vambhurkar, G.; Kumar, R.; Pandey, G.; Singh, G.; Wagh, S.; Kanaujiya, S.; Arya, D. K.; Sharma, A.; Shinde, A.; Prasad, S. B.; Chandankar, S.; Shinde, S.; Sharma, A.; Rajinikanth, P. S.; Khatri, D. K.; Asthana, A.; Srivastava, S. Docetaxel and Niclosamide-Loaded Nanofiber Systems for Improved Chemo-Therapeutic Activity and Resistance Reversal in Prostate Cancer. Drug Development and Industrial Pharmacy 2025, 51, 132–143. https://doi.org/10.1080/03639045.2025.2453533
  76. Singh, G.; Famta, P.; Shah, S.; Vambhurkar, G.; Pandey, G.; Kumar, R.; Kumar, P.; Mourya, A.; Madan, J.; Srivastava, S.; Khatri, D. K. Nanoparticle-Enhanced Delivery of Resveratrol for Targeted Therapy of Glioblastoma: Modulating the Akt/GSK-3β/NF-kB Pathway in C6 Glioma Cells. Brain Research 2025, 1848, 149411. https://doi.org/10.1016/j.brainres.2024.149411
  77. Srinivasarao, D. A.; Shah, S.; Famta, P.; Vambhurkar, G.; Jain, N.; Pindiprolu, S. K. S. S.; Sharma, A.; Kumar, R.; Padhy, H. P.; Kumari, M.; Madan, J.; Srivastava, S. Unravelling the Role of Tumor Microenvironment Responsive Nanobiomaterials in Spatiotemporal Controlled Drug Delivery for Lung Cancer Therapy. Drug Delivery and Translational Research 2025, 15, 407–435. https://doi.org/10.1007/s13346-024-01673-z
  78. Famta, P.; Shah, S.; Vambhurkar, G.; Pandey, G.; Bagasariya, D.; Kumar, K. C.; Prasad, S. B.; Shinde, A.; Wagh, S.; Srinivasarao, D. A.; Kumar, R.; Khatri, D. K.; Asthana, A.; Srivastava, S. Amelioration of Breast Cancer Therapies through Normalization of Tumor Vessels and Microenvironment: Paradigm Shift to Improve Drug Perfusion and Nanocarrier Permeation. Drug Delivery and Translational Research 2025, 15, 389–406. https://doi.org/10.1007/s13346-024-01669-9
  79. Famta, P.; Shah, S.; Dey, B.; Kumar, K. C.; Bagasariya, D.; Vambhurkar, G.; Pandey, G.; Sharma, A.; Srinivasarao, D. A.; Kumar, R.; Guru, S. K.; Raghuvanshi, R. S.; Srivastava, S. Despicable Role of Epithelial–Mesenchymal Transition in Breast Cancer Metastasis: Exhibiting De Novo Restorative Regimens. Cancer Pathogenesis and Therapy 2025, 3, 30–47. https://doi.org/10.1016/j.cpt.2024.01.001
  80. Ajmal, C. S.; Yerram, S.; Abishek, V.; Nizam, V. P. M.; Aglave, G.; Patnam, J. D.; Raghuvanshi, R. S.; Srivastava, S. Innovative Approaches in Regulatory Affairs: Leveraging Artificial Intelligence and Machine Learning for Efficient Compliance and Decision-Making. The AAPS Journal 2025, 27. https://doi.org/10.1208/s12248-024-01006-5
  81. Sikder, A.; Pasupuleti, V.; Khairnar, P.; Phatale, V.; Amulya, E.; Wagh, S. S.; Negi, M.; Asthana, A.; Raghuvanshi, R. S.; Khatri, D. K.; Srivastava, S. Deciphering Convection Enhanced Delivery: A Paradigm Shift for Circumventing Glioblastoma Multiforme. Journal of Drug Delivery Science and Technology 2025, 103, 106398. https://doi.org/10.1016/j.jddst.2024.106398
  82. Chaugule, P. D.; Varpe, P. C.; Tandulje, A. A.; Raghuvanshi, R. S.; Srivastava, S. Expedited Pathway Insights: Unveiling Oncology and Non-Oncology Drug Approvals and Withdrawals of USFDA and EMA. Critical Reviews in Oncology/Hematology 2025, 205, 104539. https://doi.org/10.1016/j.critrevonc.2024.104539
  83. Shah, S.; Famta, P.; Sharma, A.; Kumar, R.; Pandey, G.; Vambhurkar, G.; Srinivasarao, D. A.; Shinde, A.; Prasad, S. B.; Asthana, A.; Srivastava, S. Quality by Design Empowered Preparation of Itraconazole Albumin Nanoparticles for Prostate Cancer. Drug Delivery and Translational Research 2025, 15, 253–268. https://doi.org/10.1007/s13346-024-01592-z
  84. Nene, S.; Devabattula, G.; Vambhurkar, G.; Tryphena, K. P.; Singh, P. K.; Khatri, D. K.; Godugu, C.; Srivastava, S. High Mobility Group Box 1 Cytokine Targeted Topical Delivery of Resveratrol Embedded Nanoemulgel for the Management of Atopic Dermatitis. Drug Delivery and Translational Research 2025, 15, 134–157. https://doi.org/10.1007/s13346-024-01565-2
  85. Reddy, G. N.; Gottimukkula, B. R.; Bhalerao, H. A.; Talari, K.; Sonti, R. Metabolite Identification of Ripretinib by UPLC-ESI-MS/MS: In Silico Prediction, In Vitro Metabolism, and Stability Assessment. Food and Chemical Toxicology 2025, 206, 115761. https://doi.org/10.1016/j.fct.2025.115761
  86. Reddy, G. N.; Palepu, M. S. K.; Sonti, R. LC-MS/MS-Based Investigation of Pharmacokinetic Interactions Between CYP3A4 Substrates Enzalutamide and Repaglinide in Rats. RSC Analytical Methods 2025, 17, 9565. https://doi.org/10.1039/d5ay01451d
  87. Dhurjad, P.; Bazaz, R.; Pati, S.; Dandekar, M. P.; Godugu, C.; Sonti, R. Structure and Activity of Conopressins: Insights into In Silico Oxytocin/V2 Receptor Interactions, Anti-Inflammatory Potential, and Behavioural Studies. RSC Medicinal Chemistry 2025, 16, 4106. https://doi.org/10.1039/d5md00288e
  88. Singampalli, A.; Bandela, R.; Bakchi, B.; Maddipatla, S.; Kumar, P.; Bellapukonda, S. M.; Agnivesh, P. K.; Parida, K. K.; Giovannuzzi, S.; Biernacki, K.; Bonardi, A.; Gratteri, P.; Bhalerao, H. A.; Sonti, R.; Nanduri, S.; Supuran, C. T.; Kalia, N. P.; Yaddanapudi, M. V. Exploring Indole-Linked Triazole Sulfonamide Derivatives as Potent Mycobacterial Carbonic Anhydrase Inhibitors: Leveraging a Tail Approach for the Design, Synthesis, and In Silico Studies—An In-Depth Multidisciplinary Study. Journal of Medicinal Chemistry 2025, 68, 18370–18388. https://doi.org/10.1021/acs.jmedchem.5c01026
  89. Dhurjad, P.; Dannarm, S. R.; Shaik, K.; Wanjari, P.; Sonti, R. Conformational Heterogeneity of Pro-Pro Containing 23-Membered Ring Conopeptides by NMR. ACS Omega 2025, 10, 54030. https://doi.org/10.1021/acsomega.5c05404
  90. Krishnappa, R.; Shit, S.; Dey, P.; Nayak, A.; Sahoo, D. K.; Shaik, K.; Sonti, R.; Raghothama, S.; Gowd, K. H. Comparative Study of UVA Filtering Compounds 2-Methyl/2-Amino Pyrimidine Derivatives of Avobenzone under Acidic Conditions. ACS Omega 2025, 10, 50139–50152. https://doi.org/10.1021/acsomega.5c06701
  91. Yadav, R.; Chary, P. K.; Bhalerao, H.; Srivastava, V.; Pardhi, E.; Pawar, A.; Sonti, R.; Mehra, N. K. Nanotechnology-Driven Colorectal Cancer Treatment: Coencapsulation of Irinotecan and Cyclosporine A in SNEDDS for Superior Outcomes. ACS Applied Bio Materials 2025, 8, 5883. https://doi.org/10.1021/acsabm.5c00567
  92. Ommi, O.; Bhalerao, H. A.; Malik, P.; Ali, J.; Saxena, D.; Nanduri, S.; Sonti, R.; Dasgupta, A.; Chopra, S.; Yaddanapudi, V. M. Synthesis of 1,3-Diaryl Substituted Pyrazole-Based Imidazo[1,2-a]Pyridine Carboxamides and Evaluation of Their Antitubercular Activity. Bioorganic & Medicinal Chemistry 2025, 129, 118341. https://doi.org/10.1016/j.bmc.2025.118341
  93. Dannarm, S. R.; Gottimukkula, B. R.; Dhalaram, C. S.; Reddy, G. N.; Sonti, R. Environmental Degradation of the Anticancer Drug Encorafenib: Evidence for Cyclisation through Aromatic Ring Flip under Photolytic Conditions. Microchemical Journal 2025, 214, 113885. https://doi.org/10.1016/j.microc.2025.113885
  94. Dandekar, M. P.; Guin, S.; Sammeta, S.; Saha, C.; Bhalerao, H. A.; Sonti, R. Polyherbal Formulation Mitigates Age-Associated Cognitive Deficits in Rats. Journal of Ayurveda and Integrative Medicine 2025, 16, 101131. https://doi.org/10.1016/j.jaim.2025.101131
  95. Gajula, S. N. R.; Munjal, V.; Talari, S.; Rahman, Z.; Dandekar, M. P.; Sonti, R. The Influence of a Rat Model of Depression and Gastric Ulcer on the Pharmacokinetics of Encorafenib. Biopharmaceutics & Drug Disposition 2025, 46, 67. https://doi.org/10.1002/bdd.70006
  96. Sahoo, D. K.; Nayak, A.; Dannarm, S. R.; Jahnavi, A. S.; Dikundwar, A. G.; Sonti, R.; Gowd, K. H. Pyrimidine Derivative Mimicking the Locked Enol Form of Avobenzone Acts as a Photostable UVAII and UVB Filter. Journal of Photochemistry and Photobiology A: Chemistry 2025, 459, 116099. https://doi.org/10.1016/j.jphotochem.2024.116099
  97. Maddipatla, S.; Bakchi, B.; Shinde, M. A.; Bonardi, A.; Raman, P. K.; Bhalerao, H. A.; Singampalli, A.; Nanduri, S.; Godugu, C.; Sonti, R.; Supuran, C. T. New 7-Hydroxycoumarin Acetamide Derivatives as Human Carbonic Anhydrase IX and XII Inhibitors: Design, Synthesis, Biological Evaluation and Molecular Docking Studies. Archiv der Pharmazie 2025, 358, e2400482. https://doi.org/10.1002/ardp.202400482
  98. Mukhopadhyay, N.; Sen, S.; Kumar, A.; Sandbhor, R.; Dikundwar, A. G.; Kaki, V. R. Understanding Molecular Mechanisms Behind the Anti-Inflammatory Effects of Machilus macrantha (Gulmavu) by Network Pharmacology and Molecular Modeling Approach. Journal of Computational Biophysics and Chemistry 2025, 24 (8), 985–1007.
  99. Narukulla, D. K.; Kaki, V. R. Sustainable Synthesis of Melitracen HCl and Its Key Intermediate, 10,10-Dimethylanthrone: A Green Solvent-Driven and Economically Efficient Approach with Comprehensive Sustainability Analysis Using iGAL 2.0. Journal of the Indian Chemical Society 2025, 102, 102067. (IF 3.4)
  100. Shaikh, A. S.; Kumar, A.; Makhal, P. N.; Ikhe, A. S.; Bhale, N.; Dikundwar, A. G.; Kaki, V. R. Selective C3 Functionalization of 4H-Pyrido[1,2-a]pyrimidin-4-Ones via Glyoxylic Acid: Tuning Products with Temperature and Solvents. Asian Journal of Organic Chemistry 2025, 14 (5), e202400790. (IF 2.7)
  101. Narukulla, D. K.; Vattikonda, L.; Kaki, V. R. Towards Sustainable and Scalable Synthesis of Amitriptyline Hydrochloride, Minoxidil, and Pyrrolidinyl Diaminopyrimidine Oxide. Journal of the Indian Chemical Society 2025, 101805. (IF 3.4)
  102. Narukulla, D. K.; Kumar, A.; Kaki, V. R. Sustainability at Scale: Implementing a Green Solvent Approach for Grignard Reactions in the Synthesis of Key Intermediates for Active Pharmaceutical Ingredients (APIs). Journal of the Indian Chemical Society 2025, 101807. (IF 3.4)
  103. Chauhan, Y.; Kumawat, A.; Singh, A.; Shankaraiah, N.; Kaki, V. R. Unravelling the Potential of Small Molecule Tumor Necrosis Factor-α (TNF) Inhibitors: A Comprehensive Review. Bioorganic & Medicinal Chemistry 2025, 130, 118344.
  104. Shaikh, A. S.; Chilvery, S.; Patil, S.; Mourya, A.; Kumar, A.; Sharma, A.; Ikhe, A. S.; ...; Kaki, V. R. Unveiling Tetrahydroberberine–1,3,4-Oxadiazole Hybrids as Potent Anticancer Agents and MMP-9 Inhibitors with Comprehensive Insights from In Silico, In Vitro, and Ex Vivo Permeation Studies. Bioorganic Chemistry 2025, 163, 108791. (IF 4.7)
  105. Dandekar, M. P.; Tadas, M.; Satthi, S.; Jangli, A.; Shaikh, A. S.; Gajula, S. N. R.; Kaki, V. R.; Sonti, R. Oxyberberine Revokes Letrozole-Induced Polycystic Ovarian Syndrome and Depression-Like Behavior in Female Sprague-Dawley Rats. European Journal of Pharmacology 2025, 997, 177613.
  106. Negi, A.; Gaddam, H.; Beg, U. J.; Kaki, V. R. Synthesis of Substituted α-Carboline Derivatives by Base-Mediated Annulation of Azaindoles with Alkylidene Malononitriles. Synlett 2025, 36 (10), 1430–1434.
  107. Shaikh, A. S.; Rathod, M. S.; Vemula, D.; Makhal, P. N.; Bhandhari, V.; Kaki, V. R. Metal-Free Amidation and Selenoamidation of 2-Methylquinolines with Secondary Amines Using Selenium Dioxide, and Antibacterial Evaluation of the Products. Synlett 2025, 36 (16), 2637–2642.
  108. Negi, A.; Gupta, A. A.; Kikon, C. E.; Guru, S. K.; Kaki, V. R. The Reactivity of Indole-[3,4-b]-azepin-1,5-dione for Halogenations and Synthesis of Alkylamine Substituted Indole-[3,4-b]-azepine Derivatives. Synthetic Communications 2025, 55 (2), 166–174.
  109. Tofacitinib citrate loaded perillyl alcohol enriched functional nanostructured lipid carriers gel boosted re-pigmentation in vitiligo: Immunohistochemical, protein, and mRNA expression analysis. Journal of Drug Delivery Science and Technology (2025): 107936. Veerabomma H, Bhattacharjee S, Singothu S, Kumar J, Vulli D, Vasundhra Bhandari, and Madan J. https://doi.org/10.1016/j.jddst.2025.107936
  110. Design and synthesis of isoxazole-functionalized benzene sulphonamides as novel inhibitors of Mycobacterium tuberculosis β-carbonic anhydrases. RSC Medicinal Chemistry 16, no. 12 (2025): 6368-6379. Bandela R, Singampalli A, Maddipatla S, Kumar P, Bellapukonda SM, Ramavath R, Mahajan LS et al. https://doi.org/10.1039/D5MD00744E
  111. Genomic characterization of host gene alterations in Theileria annulata-transformed leukocytes. Communications Biology 8, no. 1 (2025): 1622. Dandasena D, Suresh A, Budhwar R, Godwin J, Singh S, Subudhi M, Moorthy VA et al. https://doi.org/10.1038/s42003-025-09005-8
  112. Epigenetic Reprogramming of Host Chromatin by the Transforming Parasite Theileria annulata. bioRxiv (2025): 2025-10. Singh S, Dandasena D, Suresh A, Subudhi M, Kamble S, Murthy S, Vasundhra Bhandari, and Sharma P. https://doi.org/10.1101/2025.10.27.684985
  113. In silico exploration of bioactive compounds targeting the CrtM to impede Staphylococcus aureus drug resistance: Pigment inhibitors. Computational Biology and Chemistry (2025): 108707. Munagalasetty S, Khan S, Kale V, and Vasundhra Bhandari. https://doi.org/10.1016/j.compbiolchem.2025.108707
  114. Exploring spirocyclic isoquinoline-piperidine compounds in tuberculosis therapy: ADMET profiling, docking, DFT, MD simulations, and MMGBSA analysis. Computational Biology and Chemistry 118 (2025): 108447. Bellapukonda SM, Singothu S, Singampalli A, Bandela R, Kumar P, Yaddanapudi VM, Vasundhra Bhandari, Nanduri S, Enneiymy M, and AlAjm MF. https://doi.org/10.1016/j.compbiolchem.2025.108447
  115. Natural products and nanotechnology: next-generation therapies for infectious diseases. Frontiers in Pharmacology 16 (2025): 1682331. Serrano DR, Oliveira Silva E, and Vasundhra Bhandari. https://doi.org/10.3389/fphar.2025.1682331
  116. Exploring the Antiproliferative Potential of Aurone Derivatives through In Vitro Assays and a Network Pharmacology Study. Synlett 36, no. 15 (2025): 2279-2284. Debbarma S, Mallik P, Brahma U, Vasundhra Bhandari, Debbarma A, and Acharya PC. https://doi.org/10.1055/a-2654-5235
  117. Chondroitin Sulfate-Mediated Targeted Delivery of Docetaxel and Silibinin-Loaded Nanoparticles for Amelioration of Anticancer Efficacy in Breast Cancer. ACS Applied Bio Materials 8, no. 9 (2025): 8126-8145. Aalhate M, Mahajan S, Kumar R, Kumar A, Jangir B, Munagalasetty S, Brahma U et al. https://doi.org/10.1021/acsabm.5c01098
  118. Computational assessment of marine natural products as LasR inhibitors for attenuating quorum sensing in Pseudomonas aeruginosa. Journal of Biomolecular Structure and Dynamics 43, no. 12 (2025): 6094-6108. Singothu S and Vasundhra Bhandari. https://doi.org/10.1080/07391102.2024.2319110
  119. Enhancing oral bioavailability of pazopanib via co-amorphous system: Formulation, characterization, pharmacokinetics and toxicity evaluation. Colloids and Surfaces B: Biointerfaces (2025): 115034. Rode K, Maji I, Dhuri A, Manoharan B, Kanp T, Athavan E, Munagalasetty S et al. https://doi.org/10.1016/j.colsurfb.2025.115034
  120. Berberine chloride nanoemulgel enriched with clove oil attenuated monobenzone-induced experimental vitiligo in C57BL/6 mice: Pharmaceutical, molecular modeling, biochemical, protein, and mRNA expression analysis. International Journal of Pharmaceutics (2025): 126048. Veerabomma H, Kumar J, Bhattacharjee S, Singothu S, Atram D, Vasundhra Bhandari, Kumar R, and Madan J. https://doi.org/10.1016/j.ijpharm.2025.126048
  121. Targeting ACOD1 in Sepsis: A Virtual Screening and Molecular Dynamics Approach. ChemistrySelect 10, no. 29 (2025): e00184. Singothu S, Munagalasetty S, and Vasundhra Bhandari. https://doi.org/10.1002/slct.202500184
  122. Dysregulation of Host Histone Acetylation by Acinetobacter baumannii: A Novel Mechanism for Autophagy Inhibition and Bacterial Survival. ACS Infectious Diseases 11, no. 7 (2025): 1922-1933. Singothu S, Kinkar D, Vulli D, Brahma U, Bandaru RK, and Vasundhra Bhandari. https://doi.org/10.1021/acsinfecdis.5c00080
  123. Development of venetoclax with 2-hydroxypropyl-beta-cyclodextrin inclusion complex for improved bioavailability. Journal of Biomolecular Structure and Dynamics 43, no. 9 (2025): 4847-4864. Patil SK, Chary PS, Maddipatla S, Madhavi YV, Singothu S, Bhandari V, et al. https://doi.org/10.1080/07391102.2024.2305695
  124. Benchmarking of pH-responsive mixed micelles for repurposed breast cancer therapy of ibrutinib with molecular modeling and pharmacokinetic insights. Journal of Materials Chemistry B 13, no. 23 (2025): 6819-6842. Maji I, Munagalasetty S, Naraharisetti LT, Athavan E, Mahajan S, Aalhate M, Gupta U, Yadav P, Vasundhra Bhandari, Godugu C, Chourasia MK, and Singh PK. https://doi.org/10.1039/d5tb00419e
  125. Theileria annulata Hijacks Host Signaling: Integrated Phosphoproteomics and Transcriptomics Unveils ERK1/2 as a Central Regulator of Host Transcription Factors. Molecular & Cellular Proteomics 24, no. 6 (2025): 100992. Dandasena D, Suresh A, Vasundhra Bhandari, Roy S, and Sharma P. https://doi.org/10.1016/j.mcpro.2025.100992
  126. Urolithin improves α-synuclein aggregation and DNMT1 expression in rotenone model of Parkinson's disease. Neurotoxicology 108 (2025): 246-262. Devi A, Munagalasetty S, Kumar P, Kumar R, Vasundhra Bhandari, and Dandekar MP. https://doi.org/10.1016/j.neuro.2025.04.009
  127. Fabrication of amorphous solid dispersion of Entacapone for enhanced solubility and dissolution rate: Morphology, solid state characterization, In silico molecular docking studies. Journal of Molecular Structure 1324 (2025): 140851. Dhuri A, Kanp T, Sarma AVS, Nair R, Paul P, Sharma B, Munagalasetty S, Vasundhra Bhandari, and Singh PK. https://doi.org/10.1016/j.molstruc.2024.140851
  128. Proteome-wide identification of druggable targets and inhibitors for multidrug-resistant Pseudomonas aeruginosa using an integrative subtractive proteomics and virtual screening approach. Heliyon 11, no. 4 (2025). Vemula D and Vasundhra Bhandari. https://doi.org/10.1016/j.heliyon.2025.e42584
  129. Simultaneous Quantitative Determination of Five Process-Relevant Impurities in Menatetrenone. Separation Science Plus. 2025; 8(1):e202400244. Agade S, Bhale NA, Pulipati P, Shaik NM, Samanthula G, and Dikundwar AG. https://doi.org/10.1002/sscp.202400244
  130. Transition Metal-Free One-Pot Tandem Chemoselective Reduction and Cyclization of 3/5-(2-Nitrophenyl)-1H-pyrazoles Using Sodium Dithionite. Organic & Biomolecular Chemistry. 2025; 23(24):5812–5820. Srikanth D, Shejul GD, Joshi SV, Kalam A, Jahnavi AS, Dikundwar AG, et al. https://doi.org/10.1039/d5ob00610d
  131. Pyrimidine Derivative Mimicking the Locked Enol Form of Avobenzone Acts as a Photostable UVAII and UVB Filter. Journal of Photochemistry and Photobiology A: Chemistry. 2025; 459:116099. Sahoo DK, Nayak A, Dannarm SR, Jahnavi AS, Dikundwar AG, Sonti R, and Gowd KH. https://doi.org/10.1016/j.jphotochem.2024.116099
  132. Forced Degradation Study of an Anti-Diabetic Drug Imeglimin: Impurity Profiling and Structure Elucidation Using LC-Q-ToF-MS/MS and NMR. Rapid Communications in Mass Spectrometry. 2025; 39(5):e9960. Gogikar SK, Sen S, Pathinti S, Samanthula G, and Dikundwar AG. https://doi.org/10.1002/rcm.9960
  133. Neat Amorphous Form and Amorphous Solid Dispersions of Apalutamide: A Comparative Study. Journal of Drug Delivery Science and Technology. 2025; 106:106678. Sapkal R, Devangan P, Madan J, and Dikundwar AG. https://doi.org/10.1016/j.jddst.2025.106678
  134. Selective C3 Functionalization of 4H-Pyrido[1,2-a]pyrimidin-4-Ones via Glyoxylic Acid: Tuning Products with Temperature and Solvents. Asian Journal of Organic Chemistry. 2025; 14(5):e202400790. Shaikh AS, Kumar A, Makhal PN, Ikhe AS, Bhale N, Dikundwar AG, and Rao Kaki V. https://doi.org/10.1002/ajoc.202400790
  135. An Unusual, Methylated Impurity in Diethyl Sulphate: Identification, Structure Elucidation, and Linkage with N-Methyl Impurity of an Active Pharmaceutical Ingredient. ChemistrySelect. 2025; 10(21):e04945. Bhale NA, Birajdar G, Agade S, Khemchandani R, Shekhar C, Shaik M, et al. https://doi.org/10.1002/slct.202404945
  136. Toward “Crystal De-Engineering”: Stable, Homogeneous Coamorphous Drug–Tannic Acid Systems Exhibiting Modified Dissolution Rates. Crystal Growth & Design. 2025; 25(13):5087–5096. Prajapati AK, Subha Jahnavi A, Pradhan AK, Vishwakarma A, Rahman A, Dikundwar AG, and Thomas SP. https://doi.org/10.1021/acs.cgd.5c00599
  137. Exploration of Pyrazole-Based Pyridine-4-carbohydrazide Derivatives as Drug-Resistant Mtb Agents: Design, Synthesis, Biological Evaluation, and In Silico Studies. Future Medicinal Chemistry. 2025; 17(12):1391–1405. Kumar P, Malik P, Ali J, Saxena D, Singampalli A, Bandela R, and Yaddanapudi VM. https://doi.org/10.1080/17568919.2025.2525069
  138. Mitochondria-Targeting SIRT3 Activator Effectively Controls Bleomycin-Induced Pulmonary Fibrosis. BioFactors. 2025; 51(4):e70032. Devabattula G, Bakchi B, Sharma A, Sidhartha NN, Dikundwar AG, Yeddanapudi VM, and Godugu C. https://doi.org/10.1002/biof.70032
  139. Exploration of New Dihydroindazole Derivatives as Promising Anti-TB Agents: Design, Synthesis, In Silico, and Biological Evaluation. Archiv der Pharmazie. 2025; 358(8):e70074. Kumar P, Malik P, Ali J, Saxena D, Singampalli A, Rani B, et al. https://doi.org/10.1002/ardp.70074
  140. Ever-Increasing Role of Computational Tools in Solid-State Pharmaceutics: Advancing Drug Development with Enhanced Molecular Understanding and Risk Assessment. Molecular Pharmaceutics. 2025; 22(9):5165–5192. Sharma A, Shah S, Wagh S, Pandey G, Pradhan AK, Shukla S, et al. https://doi.org/10.1021/acs.molpharmaceut.5c00296
  141. Exploration of Pyridine-4-hydrazide Derivatives as Promising Antitubercular Agents: Synthesis, Biological Evaluation, and In Silico Studies. ChemistrySelect. 2025; 10(36):e01301. Kumar P, Malik P, Ali J, Saxena D, Singampalli A, Bandela R, et al. https://doi.org/10.1002/slct.202501301
  142. Metal-Organic Frameworks as Therapeutic Chameleons: Revolutionizing Cancer Therapy Employing Novel Nanoarchitectonics. Asian Journal of Pharmaceutical Sciences. 2025; 20(5):101054. Prasad SB, Shinde A, Srinivasrao DA, Famta P, Shah S, Kolipaka T, et al. https://doi.org/10.1016/j.ajps.2025.101054
  143. Sodium Dithionite-Mediated One-Pot, Tandem Reductive Cyclization of 2-(2-Nitrophenyl)quinazolin-4(3H)-one with Diverse Aldehydes and Glyoxals. Synthesis. 2025; 57(20):2983–2996. Kalam A, Tiwari M, Pawar G, Srikanth D, Joshi SV, Bhale NA, et al. https://doi.org/10.1055/a-2655-4585
  144. Understanding Molecular Mechanisms behind the Anti-Inflammatory Effects of Machilus macrantha (Gulmavu) by Network Pharmacology and Molecular Modeling Approach. Journal of Computational Biophysics and Chemistry. 2025; 24(8):985–1007. Mukhopadhyay N, Sen S, Kumar A, Sandbhor R, Dikundwar AG, and Kaki VR. https://doi.org/10.1142/S2737416525500061
  145. Metal-Free, Solvent-Controlled Divergent Synthesis of Substituted α-Keto Amides/Benzimidazoquinazolines: DFT, Crystallographic Analysis, and In Silico Studies. Journal of Molecular Structure. 2025; 144581. Dastari S, Kopuri S, Jha A, Avvaru SJ, Dikundwar AG, and Shankaraiah N. https://doi.org/10.1016/j.molstruc.2025.144581
  146. Drug–Drug Coamorphous System of Tadalafil and Finasteride for Enhanced Pharmaceutical Performance. Molecular Pharmaceutics. 2025; 23(1):127–138. Bhale NA, Subha Jahnavi A, Khemchandani R, Vambhurkar G, Suradkar RV, Shah S, et al. https://doi.org/10.1021/acs.molpharmaceut.5c00513
  147. ‘Dawa-ul-kurkum’, a Potential Anti-Diabesity Polyherbal Formulation: Phyto-Metabolomics, Network Pharmacology, Molecular Docking and Simulation Studies Supported by In Vitro Activity. Journal of Computational Biophysics and Chemistry. 2025; 24(10):1311–1329. Sen S, Mukhopadhyay N, Singh S, Kaki VR, Somabattini RA, Nanjappan SK, and Dikundwar AG. https://doi.org/10.1142/S273741652550022X
  148. Rana, P.; Supriya, M. S.; Srikanth, D.; Ammara, A.; Warake, R.; Gandhe, H.; Yaddanapudi, V. M.; Supuran, C. T.; Nanduri, S. Exploration of Novel 4-Substituted Coumarin Derivatives as Selective Human Carbonic Anhydrase IX and XII Inhibitors: Synthesis, Biological Evaluation, and In Silico Studies. Chem. Biodivers. 22(12) (2025): e01800. https://doi.org/10.1002/cbdv.202501800
  149. Kumar, P.; Singampalli, A.; Bandela, R.; Bellapukonda, S. M.; Korra, L. N.; Kodi, R.; Ghosh, S.; Dalal, A.; Agnivesh, P. K.; Devi, A.; Nanduri, S.; Kalia, N. P.; Paoletti, N.; Bonardi, A.; Gratteri, P.; Supuran, C. T.; Yaddanapudi, V. M. Exploration of New Pyrazole–Hydrazone–Benzenesulfonamide Conjugates as Potent Mycobacterial Carbonic Anhydrase Inhibitors: Design, Synthesis, and Biological Evaluation. ChemMedChem 20(23) (2025): e202500633. https://doi.org/10.1002/cmdc.202500633
  150. Maddipatla, S.; Bakchi, B.; Agnivesh, P. K.; Meshram, S.; Mazumdar, C. K.; Ghouse, S. M.; Singampalli, A.; Rani, B.; Kumar, P.; Nanduri, S.; Kalia, N. P.; Yaddanapudi, V. M. Identification of Novel MmpL3 Inhibitors Using In Silico Methods: Virtual Screening, Rational Design, and Biological Evaluation. J. Mol. Struct. 1354 (2025): 144902. https://doi.org/10.1016/j.molstruc.2025.144902
  151. Yerram, S.; Nizam, V. M.; Srivastava, S.; Nanduri, S. Nitrosamine Contamination in Pharmaceuticals: A Retrospective Regulatory Analysis of USFDA Recalls and Risk Mitigation Strategies (2018–2025). Ther. Innov. Regul. Sci. 60(2) (2025): 519–533. https://doi.org/10.1007/s43441-025-00891-y
  152. Kalam, A.; Tiwari, M.; Pawar, G.; Srikanth, D.; Joshi, S. V.; Bhale, N. A.; Dikundwar, A. G.; Yeddanapudi, M. V.; Nanduri, S. Sodium Dithionite-Mediated One-Pot, Tandem Reductive Cyclization of 2-(2-Nitrophenyl)quinazolin-4(3H)-one with Diverse Aldehydes and Glyoxals. Synthesis 57(20) (2025): 2983–2996. https://doi.org/10.1055/a-2655-458
  153. Bellapukonda, S. M.; Singothu, S.; Singampalli, A.; Bandela, R.; Kumar, P.; Yaddanapudi, V. M.; Bhandari, V.; Nanduri, S.; Enneiymy, M.; AlAjm, M. F.; Oubella, A. Exploring Spirocyclic Isoquinoline-Piperidine Compounds in Tuberculosis Therapy: ADMET Profiling, Docking, DFT, MD Simulations, and MMGBSA Analysis. Comput. Biol. Chem. 118 (2025): 108447. https://doi.org/10.1016/j.compbiolchem.2025.108447
  154. Bandela, R.; Tupare, R. R.; Saxena, D.; Maitra, R.; Singampalli, A.; Bellapukonda, S. M.; Kumar, P.; Bakchi, B.; Polshettiwar, S.; Nanduri, S.; Chopra, S.; Yaddanapudi, V. M. Synthesis and Antibacterial Evaluation of 5-(3-Nitrophenyl)-N'-Arylisoxazole-3-Carbohydrazide Derivatives Against Carbapenem-Resistant Acinetobacter baumannii. Eur. J. Med. Chem. 300 (2025): 118154. https://doi.org/10.1016/j.ejmech.2025.118154
  155. Kumar, P.; Singampalli, A.; Bandela, R.; Bellapukonda, S. M.; Maddipatla, S.; Dalal, A.; Devi, A.; Nanduri, S.; Kalia, N. P.; Paoletti, N.; Supuran, C. T.; Madhavi, Y. V. Structural Insights into Arylidenehydrazinyl Benzenesulfonamides as Potent Mycobacterial Carbonic Anhydrase Inhibitors. Future Med. Chem. 17(17) (2025): 2131–2144. https://doi.org/10.1080/17568919.2025.2552642
  156. Joshi, S. V.; Soujanya, D.; Supriya, M. S.; Yaddanapudi, V. M.; Nanduri, S. Glycogen Synthase Kinase 3β (GSK-3β) Inhibitors—A Patent Update (2019–2024). Expert Opin. Ther. Pat. 35(9) (2025): 933–945. https://doi.org/10.1080/13543776.2025.2536003
  157. Kumar, P.; Malik, P.; Ali, J.; Saxena, D.; Singampalli, A.; Bandela, R.; Bakchi, B.; Bhale, N. A.; Dikundwar, A. G.; Nanduri, S.; Dasgupta, A.; Chopra, S.; Madhavi, Y. V. Exploration of Pyridine-4-Hydrazide Derivatives as Promising Antitubercular Agents: Synthesis, Biological Evaluation, and In Silico Studies. ChemistrySelect 10(36) (2025): e01301. https://doi.org/10.1002/slct.202501301
  158. Singampalli, A.; Bandela, R.; Bakchi, B.; Maddipatla, S.; Kumar, P.; Bellapukonda, S. M.; Agnivesh, P. K.; Parida, K. K.; Giovannuzzi, S.; Biernacki, K.; Bonardi, A.; Gratteri, P.; Bhalerao, H. A.; Sonti, R.; Nanduri, S.; Supuran, C. T.; Kalia, N. P.; Yaddanapudi, M. V. Exploring Indole-Linked Triazole Sulfonamide Derivatives as Potent Mycobacterial Carbonic Anhydrase Inhibitors: Leveraging a Tail Approach for the Design, Synthesis, and In Silico Studies. J. Med. Chem. 68(17) (2025): 18370–18388. https://doi.org/10.1021/acs.jmedchem.5c01026
  159. Ommi, O.; Bhalerao, H. A.; Malik, P.; Ali, J.; Saxena, D.; Nanduri, S.; Sonti, R.; Dasgupta, A.; Chopra, S.; Yaddanapudi, V. M. Synthesis of 1,3-Diaryl Substituted Pyrazole-Based Imidazo[1,2-a]Pyridine Carboxamides and Evaluation of Their Antitubercular Activity. Bioorg. Med. Chem. 129 (2025): 118341. https://doi.org/10.1016/j.bmc.2025.118341
  160. Kumar, P.; Malik, P.; Ali, J.; Saxena, D.; Singampalli, A.; Rani, B.; Bellapukonda, S. M.; Devi, A.; Bhale, N. A.; Dikundwar, A. G.; Nanduri, S.; Dasgupta, A.; Chopra, S.; Madhavi, Y. V. Exploration of New Dihydroindazole Derivatives as Promising Anti-TB Agents: Design, Synthesis, In Silico, and Biological Evaluation. Arch. Pharm. 358(8) (2025): e70074. https://doi.org/10.1002/ardp.70074
  161. Rokkam, S. K.; Chowdhury, S.; Inabathina, Y.; Sripada, L.; Nanduri, S.; Karanam, B.; Golakoti, N. R. Novel 3,19-(N-Phenyl-3-(4-Fluorophenyl)-Pyrazole) Acetal of Andrographolide Promotes Cell Cycle Arrest and Apoptosis in MDA-MB-231 Breast Cancer Cells. Pharmaceuticals 18(7) (2025): 1026. https://doi.org/10.3390/ph18071026
  162. Kumar, P.; Malik, P.; Ali, J.; Saxena, D.; Singampalli, A.; Bandela, R.; Bellapukonda, S. M.; Rajyalakshmi, S. I.; Bhale, N. A.; Dikundwar, A. G.; Nanduri, S.; Dasgupta, A.; Chopra, S.; Yaddanapudi, V. M. Exploration of Pyrazole-Based Pyridine-4-Carbohydrazide Derivatives as Drug-Resistant Mtb Agents: Design, Synthesis, Biological Evaluation, and In-Silico Studies. Future Med. Chem. 17(12) (2025): 1391–1405. https://doi.org/10.1080/17568919.2025.2525069
  163. Rana, P.; Supriya, M. S.; Ahmad, M. N.; Imran, M.; Malik, P.; Mahajan, R.; Asthana, A.; Madhavi, Y.; Dasgupta, A.; Chopra, S.; Nanduri, S. Synthesis, Biological Evaluation, and Structure–Activity Relationships of Pyrrole Coumarin Conjugates Against Mycobacterium tuberculosis. ChemistrySelect 10(28) (2025): e1069. https://doi.org/10.1002/slct.202501069
  164. Singampalli, A.; Bandela, R.; Bakchi, B.; Giovannuzzi, S.; Biernacki, K.; Agnivesh, P. K.; Nanduri, S.; Kalia, N. P.; Supuran, C. T.; Yaddanapudi, V. M. Exploration of 3-Substituted Benzofuran-Tethered Sulfamoyl Triazoles as Carbonic Anhydrase Inhibitors: Design, Synthesis, and Biological Evaluation. ChemMedChem (2025): 2500080. https://doi.org/10.1002/cmdc.202500080
  165. Radapaka, K.; Mourya, A.; Singh, H.; Loharkar, S.; Bansode, A.; Guru, S. K.; Doijad, N.; Nanduri, S.; Madan, J. Glucosamine Sulphate Endorsed Ibuprofen Nanocrystals Burdened Polymeric Gel Demonstrated Multidimensional Anti-Inflammatory and Cartilage Protective Potential in Experimental Knee Osteoarthritis: In Vitro and In Vivo Studies. Int. J. Pharm. 677 (2025): 125660. https://doi.org/10.1016/j.ijpharm.2025.125660
  166. Akki, A. J.; Nanduri, S.; Patil, S. V.; Das, K. K.; Parvatikar, P. Exploring the microRNA-Mitochondrial Nexus in Hepatocellular Carcinoma. Mitochondrion (2025): 102045. https://doi.org/10.1016/j.mito.2025.102045
  167. Singampalli, A.; Bandela, R.; Kumar, P.; Bakchi, B.; Maddipatla, S.; Bellapukonda, S. M.; Nanduri, S.; Shukla, R.; Mishra, K.; Madhavi, Y. V. Exploration of Benzofuran/Indole-Chalcone Conjugated 1,2,3-Triazole Hybrids as Candida glabrata Agents: Design, Synthesis, Biological Evaluation, Molecular Docking, and In Silico ADMET Analysis. Chem. Biodivers. 22(8) (2025): e202500345. https://doi.org/10.1002/cbdv.202500345
  168. Kumar, P.; Singampalli, A.; Bandela, R.; Srimounika, B.; Rajyalakshmi, S. I.; Devi, A.; Nanduri, S.; Madhavi, Y. V. Spirocyclic Compounds: Potential Drug Leads in the Fight Against Mycobacterium tuberculosis. Future Med. Chem. 17(7) (2025): 819–837. https://doi.org/10.1080/17568919.2025.2479413
  169. Srikanth, G.; Beda, D. P.; Dwivedi, A. R.; Duddukuri, N. K.; Nanduri, S.; Patel, J. Promising New Anti-TIGIT Agents: Stealthy Allies in Cancer Immunotherapy. Clin. Transl. Sci. 18(4) (2025): e70212. https://doi.org/10.1111/cts.70212
  170. Bandela, R.; Sahoo, S. K.; Mukhopadhyay, A.; Imran, M.; Singampalli, A.; Maddipatla, S.; Bellapukonda, S. M.; Panchal, D.; Nanduri, S.; Dasgupta, A.; Chopra, S.; Yaddanapudi, V. M. Design, Synthesis and Biological Evaluation of Ethyl 5-(1-Benzyl-1H-Indol-5-yl) Isoxazole-3-Carboxylates as Antimycobacterial Agents. ChemMedChem 20(7) (2024): e20240090233. https://doi.org/10.1002/cmdc.202400902
  171. Maddipatla, S.; Agnivesh, P. K.; Bakchi, B.; Nanduri, S.; Kalia, N. P.; Yaddanapudi, V. M. New Pyrazole-Based Derivatives Targeting MmpL3 Transporter in Mycobacterium tuberculosis: Design, Synthesis, Biological Evaluation and Molecular Docking Studies. Mol. Divers. 29(6) (2025): 6437–6458. https://doi.org/10.1007/s11030-025-11152-3
  172. Bellapukonda, S. M.; Bandela, R.; Singampalli, A.; Srikanth, D.; Kumar, P.; Nanduri, S.; Yaddanapudi, V. M. A Systematic Review on the Anti-Microbial Activities and Structure-Activity Relationship (SAR) of Quinoxaline Derivatives. Eur. J. Med. Chem. 289 (2025): 117472. https://doi.org/10.1016/j.ejmech.2025.117472
  173. Bakchi, B.; Devabattula, G.; Maddipatla, S.; Singampalli, A.; Porna, D. K.; Nanduri, S.; Sharma, A.; Godugu, C.; Yaddanapudi, V. M. New Indole-Based Phenylthiazolyl-2, 4-dihydropyrazolones as Tubulin Polymerization Inhibitors: Multicomponent Synthesis, Cytotoxicity Evaluation, and In Silico Studies. ChemMedChem 2024, 20(5), e202400817. https://doi.org/10.1002/cmdc.202400817
  174. Bandela, R.; Singampalli, A.; Maddipatla, S.; Kumar, P.; Bellapukonda, S. M.; Ramavath, R.; Mahajan, L. S.; Nanduri, S.; Vemula, D.; Dalal, A.; Bhandari, V.; Gratteri, P.; Paoletti, N.; Bonardi, A.; Supuran, C. T.; Yaddanapudi, V. M. Design and Synthesis of Isoxazole-Functionalized Benzene Sulphonamides as Novel Inhibitors of Mycobacterium tuberculosis β-Carbonic Anhydrases. RSC Med. Chem. 2025, 16(12), 6368–6379. https://doi.org/10.1039/d5md00744e
  175. Kumar, P.; Singampalli, A.; Bandela, R.; Bellapukonda, S. M.; Nanduri, S.; Yaddanapudi, V. M. Therapeutic Potential of Spiro Compounds Against Staphylococcus aureus: A Comprehensive Review. RSC Med. Chem. 2025, 16(12), 5925–5952. https://doi.org/10.1039/d5md00497g
  176. Singampalli, A.; Kumar, P.; Bandela, R.; Bellapukonda, S. M.; Nanduri, S.; Yaddanapudi, V. M. Indazole—An Emerging Privileged Scaffold: Synthesis and Its Biological Significance. RSC Med. Chem. 2025, 16(11), 5196–5221. https://doi.org/10.1039/d5md00336a
  177. Srikanth, D.; Shejul, G. D.; Joshi, S. V.; Kalam, A.; Jahnavi, A. S.; Dikundwar, A. G.; Chopra, S.; Yaddanapudi, M. V.; Nanduri, S. Transition Metal-Free One-Pot Tandem Chemoselective Reduction and Cyclization of 3/5-(2-Nitrophenyl)-1H-Pyrazoles Using Sodium Dithionite. Org. Biomol. Chem. 2025, 23(24), 5812–5820. https://doi.org/10.1039/d5ob00610d
  178. Tamang, N.; Pati, D. R.; Sripada, L.; Nanduri, S.; Golakoti, N. R. Synthesis, Structural, Spectroscopic, and Anticancer Studies of 3,19-Furfurylidene-12(S)-thiophenyl-14-deoxy-andrographolide Against 58 Different Cell Lines of Nine Different Cancer Types. ChemistrySelect 2025, 10(3), e202404092. https://doi.org/10.1002/slct.202404092
  179. Maddipatla, S.; Bakchi, B.; Shinde, M. A.; Bonardi, A.; Raman, P. K.; Bhalerao, H. A.; Singampalli, A.; Nanduri, S.; Godugu, C.; Sonti, R.; Supuran, C. T.; Yaddanapudi, V. M. New 7-Hydroxycoumarin Acetamide Derivatives as Human Carbonic Anhydrase IX and XII Inhibitors: Design, Synthesis, Biological Evaluation and Molecular Docking Studies. Arch. Pharm. 2025, 358(1), e2400482. https://doi.org/10.1002/ardp.202400482
  180. Ommi, O.; Dhopat, P. S.; Sau, S.; Estharla, M. R.; Nanduri, S.; Kalia, N. P.; Yaddanapudi, V. M. Design, Synthesis, and Biological Evaluation of Pyrazole–Ciprofloxacin Hybrids as Antibacterial and Antibiofilm Agents Against Staphylococcus aureus. RSC Med. Chem. 2025, 16(1), 420–428. https://doi.org/10.1039/d4md00623b
  181. Srikanth, D.; Shanthi, K.; Paoletti, N.; Joshi, S. V.; Shaik, M. G.; Rana, P.; Vadakattu, M.; Yaddanapudi, V. M.; Supuran, C. T.; Nanduri, S. Exploration of 1,3,5-Trisubstituted Pyrazoline Derivatives as Human Carbonic Anhydrase Inhibitors: Synthesis, Biological Evaluation and In Silico Studies. Int. J. Biol. Macromol. 2025, 280, 135890. https://doi.org/10.1016/j.ijbiomac.2024.135890
  182. Ganji Praveena; Arjun Jayachandran; Sasidhar Manda Venkata; Amit Asthana From bench to bedside: The evolution of extracellular vesicle diagnostics through microfluidic and paper-based technologies. Colloids and Surfaces B: Biointerfaces 2025, 252, 114675. https://doi.org/10.1016/j.colsurfb.2025.114675
  183. Shahila Parween; KVS Ratnam; Arjun Jayachandran; PR Raja Ram; Prajna Arpita; Harsh Vardhan Shrivastava; Amit Asthana Clinical evaluation, validation, and stability testing of a developed paper-based blood grouping diagnostic test device. Clinica Chimica Acta 2025, 572, 120276. https://doi.org/10.1016/j.cca.2025.120276
  184. Sowjanya Goli; Aditya Teja Guduru; Suman Karadagatla; Errappagari Sreehari; Ira Bhatnagar; Manoj P. Dandekar; Anamika Sharma; Dhiraj Bhatia; Amit Asthana Generation of uniform-sized spheroids using PDMS-based microwell devices as 3D cancer models for pharmacological profiling of drugs. bioRxiv 2025, 2025.09.01.673452. https://doi.org/10.1101/2025.09.01.673452
  185. Abhinav Meshram; Mohd Juned; Dr. B. Lakshmi The role of gamification in enhancing Customer loyalty: analyzing its impact on retention and lifetime value in Flipkart Plus rewards. International Journal of Engineering Development and Research 2025, 13(4), December 2025.
  186. Chetan Garg; Prerana Bhikaji Joshi; Dr. B. Lakshmi The impact of social media advertisement on consumer buying behavior for nutraceuticals in Hyderabad. International Journal of Advance Research and Innovative Ideas in Education 2025, 11(6).
  187. Harsh Keshav Bawane; Rutuja Hivarkar; Dr. B. Lakshmi; Dr. N. Rajesh Kumar Generic drugs: exploring consumer awareness and attitudes. International Journal of Engineering Development and Research 2025, 13(4), December 2025.